Medicago: Covifenz

Vaccine Type: VLP

This vaccine may also be referred to as CoVLP, MT-2766, Plant-based VLP

Vaccine Trial & Approval Tracker

This vaccine is approved.

About Trial Phases

Phase 1: 2 Trials

Phase 2: 2 Trials

Phase 3: 2 Trials

  • NCT04636697
    Argentina, Brazil, Canada, United Kingdom of Great Britain and Northern Ireland, United States of America
  • NCT05040789


1 Country

Registered Trials